As of 3:56pm ET
| -0.0099 / -2.36%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 4.93, with a high estimate of 4.93 and a low estimate of 4.93. The median estimate represents a +1,103.63% increase from the last price of 0.41.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.